Brian Steixner, MD
Urology · South Lake Tahoe, CANPI 1801952213
Payments from drug & device makers
Across 84 payments — averaging $43.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$961
- Procept Biorobotics Corporation$867
- Bluewind Medical$285
- Neotract Inc.$207
- Olympus America Inc.$177
- Sumitomo Pharma America, Inc.$165
- plus $987 from 24 others
What the payments were for
- Food & beverage$3,650100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 10 | $961 |
| Procept Biorobotics Corporation | 7 | $867 |
| Bluewind Medical | 5 | $285 |
| Neotract Inc. | 6 | $207 |
| Olympus America Inc. | 2 | $177 |
| Sumitomo Pharma America, Inc. | 10 | $165 |
| Axonics, Inc. | 5 | $116 |
| Distalmotion US | 1 | $106 |
| AbbVie(2 entities) | 5 | $102 |
| Coloplast | 2 | $56 |
| Telix Pharmaceuticals | 3 | $52 |
| Convatec Inc. | 2 | $50 |
| Boston Scientific | 2 | $49 |
| Myriad Genetic Laboratories, Inc. | 3 | $47 |
| 180 Medical, Inc. | 2 | $45 |
| Immunitybio, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $36 |
| Novartis | 2 | $34 |
| Urogen Pharma, Inc. | 2 | $31 |
| Laborie Medical Technologies Corp. | 1 | $29 |
| Bioprotect Medical, Inc. | 1 | $27 |
| Davol Inc. | 1 | $25 |
| Verity Pharmaceuticals Inc. | 1 | $22 |
| Bayer | 1 | $21 |
| Photocure Inc | 1 | $21 |
| Stryker | 1 | $19 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $19 |
| Ambu Inc. | 1 | $16 |
| Myovant Sciences Inc. | 1 | $14 |
| Tolmar Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$588
- AQUABEAM SYSTEM$436
- AquaBeam Robotic System$331
- Soltive$146
- REVI$133
- UroLift System$119
- DEXTER L6 ROBOT$106
How this compares
$3,650 in reported general payments places this provider in the 55th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 218 | $4,472 |
| Estradiol | 20 | $1,293 |
| Finasteride | 32 | $776 |
| Oxybutynin Chloride ErOxybutynin Chloride | 36 | $758 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $309 |
| Cephalexin | 44 | $95 |
| Oxybutynin Chloride | 11 | $55 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $50 |
| Phenazopyridine Hcl | 13 | $47 |
| Ciprofloxacin Hcl | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Other urology in South Lake Tahoe
- Edward UchioOrange$21.1M
- Stephen FreedlandWest Hollywood$16.7M
- Alec KooTorrance$7.4M
- Karim ChamieLos Angeles$4.3M
- Ralph ClaymanOrange$3.9M
- Siamak DaneshmandLos Angeles$3.5M
- Arnold ChinLos Angeles$3.5M
- Roger LiLoma Linda$2.3M
- John KowalczykLos Angeles$1.8M
- Arie BelldegrunLos Angeles$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.